FDA Approved: LACTULOSE — Supplemental Application (APOZEAL PHARMACEUTICALS INC)

View source ↗

Summary

FDA approved a supplemental application for Lactulose submitted by APOZEAL PHARMACEUTICALS INC, indicating an update to labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Hepatic Encephalopathy

Drugs mentioned

• LACTULOSE (Lactulose)

Snippet

SUPPL AP for LACTULOSE (LACTULOSE)